Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
8.25
-0.24 (-2.83%)
At close: Dec 15, 2025, 4:00 PM EST
8.25
0.00 (0.00%)
After-hours: Dec 15, 2025, 4:10 PM EST
Cross Country Healthcare Stock Forecast
Stock Price Forecast
The 2 analysts that cover Cross Country Healthcare stock have a consensus rating of "Hold" and an average price target of $13.81, which forecasts a 67.39% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $18.61.
Price Target: $13.81 (+67.39%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Cross Country Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $17 → $9 | Hold | Maintains | $17 → $9 | +9.09% | Dec 9, 2025 |
| Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +125.58% | Jun 17, 2025 |
| UBS | UBS | Hold Maintains $19 → $17 | Hold | Maintains | $19 → $17 | +100.00% | May 13, 2025 |
| Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +125.58% | Mar 14, 2025 |
| UBS | UBS | Hold Maintains $14 → $19 | Hold | Maintains | $14 → $19 | +125.58% | Mar 6, 2025 |
Financial Forecast
Revenue This Year
1.10B
from 1.34B
Decreased by -18.45%
Revenue Next Year
1.03B
from 1.10B
Decreased by -6.11%
EPS This Year
0.11
from -0.44
EPS Next Year
0.13
from 0.11
Increased by 21.43%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.1B | 1.1B | |
| Avg | 1.1B | 1.0B | |
| Low | 1.0B | 968.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -15.4% | 1.3% | |
| Avg | -18.5% | -6.1% | |
| Low | -22.3% | -11.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.13 | 0.18 | |
| Avg | 0.11 | 0.13 | |
| Low | 0.08 | 0.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 66.7% | |
| Avg | - | 21.4% | |
| Low | - | -45.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.